✦ LIBER ✦

583 Safety of peginterferon α-2a (40KD) (PEGASYS®) [PEG-IFNα-2a (40KD)] plus ribavirin (COPEGUS®) among pegylated interferon α-2b (12KD)/ribavirin non-responders: Interim analysis of the repeat study

✍ Scribed by D. Jensen; F. Andreone; Y. Benhamou; Y. Horsmans; M. Diago; A. Olveira Martins; G. Teuber; D. Rincon; F. Marcellin

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

575 Retreatment with peginterferon α-2a

✍ N. Gitlin; D. Jensen; A. Di Bisceglie; T. Berg; J. Salmeron; M. Rizzetto; C. Yur 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 247 KB

11 Efficacy of standard-dose and fixed-d

✍ P. Marcellin; G. Teuber; V. Canva; O. Weiland; A. Di Bisceglie; C. Brandao-Mello 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 127 KB

P.259 Retreatment with peginterferon alp

✍ P. Marcellin; G. Teuber; B. Freilich; O. Weiland; A. Di Bisceglie; C. Brandao-Me 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 119 KB

Re-treatment of interferon (IFN) plus ri

✍ S. Brillanti; A. Mangia; L. Cimino; A. Civolani; F. Fatuzzo; L. Fenoglio; M. Lev 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 166 KB